635
Views
14
CrossRef citations to date
0
Altmetric
Short Communication

Consumption of polyphenol-rich juar tea increases endothelium-bound extracellular superoxide dismutase levels in men with metabolic syndrome: link with LDL oxidizability

, , , , , , , , & show all
Pages 407-414 | Published online: 15 Jan 2013

References

  • Adachi T, Hara H, Yamada H, Yamazaki N, Yamamoto M, Sugiyama T, . 2001. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis. 159:307–312.
  • Adachi T, Inoue M, Hara H, Maehata E, Suzuki S. 2004. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol. 181:413–417.
  • Adachi T, Kodera T, Ohta H, Hayashi K, Hirano K. The heparin binding site of human extracellular-superoxide dismutase. Arch Biochem Biophys. 1992a; 297:155–161.
  • Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992b; 212:89–102.
  • Ayaori M, Ishikawa T, Yoshida H, Suzukawa M, Nishiwaki M, Shige H, . 1997. Beneficial effects of alcohol withdrawal on LDL particle size distribution and oxidative susceptibility in subjects with alcohol-induced hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 17:2540–2547.
  • Balentine DA, Wiseman SA, Bouwens LC. 1997. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 37:693–704.
  • Esterbauer H, Striegl G, Puhl H, Rotheneder M. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6:67–75.
  • Fraley AE, Tsimikas S. 2006. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol. 17:502–509.
  • Galle J, Hansen-Hagge T, Wanner C, Seibold S. 2006. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis. 185:219–226.
  • Grassi D, Mulder TP, Draijer R, Desideri G, Molhuizen HO, Ferri C. 2009. Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. J Hypertens. 27:774–781.
  • Hirano R, Kondo K, Iwamoto T, Igarashi O, Itakura H. 1997. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein. J Nutr Sci Vitaminol (Tokyo). 43:435–444.
  • Hirano-Ohmori R, Takahashi R, Momiyama Y, Taniguchi H, Yonemura A, Tamai S, . 2005. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. J Am Coll Nutr. 24:342–346.
  • Hodgson JM, Puddey IB, Croft KD, Burke V, Mori TA, Caccetta RA, Beilin LJ. 2000. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr. 71:1103–1107.
  • Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DRJr. 2008. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 299:2287–2293.
  • Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, . 2001. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 21:844–848.
  • Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, . 2001. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation. 103:799–805.
  • Inoue T, Hayashi M, Takayanagi K, Morooka S. 2002. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Atherosclerosis. 160:369–376.
  • Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, . 1997. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr. 66:261–266.
  • Jochmann N, Lorenz M, Krosigk A, Martus P, Bohm V, Baumann G, . 2008. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr. 99:863–868.
  • Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, . 2004. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation. 109:59–65.
  • Khan N, Mukhtar H. 2007. Tea polyphenols for health promotion. Life Sci. 81:519–533.
  • Kurihara H, Fukami H, Toyoda Y, Kageyama N, Tsuruoka N, Shibata H, . 2003. Inhibitory effect of oolong tea on the oxidative state of low density lipoprotein (LDL). Biol Pharm Bull. 26:739–742.
  • Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. 2000. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 101:2264–2270.
  • Laukkanen MO, Lehtolainen P, Turunen P, Aittomaki S, Oikari P, Marklund SL, Yla-Herttuala S. 2000. Rabbit extracellular superoxide dismutase: expression and effect on LDL oxidation. Gene. 254:173–179.
  • Lee MJ, Lambert JD, Prabhu S, Meng X, Lu H, Maliakal P, . 2004. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomarkers Prev. 13:132–137.
  • Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY. 2001. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr. 131:2248–2251.
  • Luo M, Kannar K, Wahlqvist ML, O'Brien RC. 1997. Inhibition of LDL oxidation by green tea extract. Lancet. 349:360–361.
  • Maddux BA, See W, Lawrence JCJr, Goldfine AL, Goldfine ID, Evans JL. 2001. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes. 50:404–410.
  • Matsuzawa Y. 2005. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb. 12:301.
  • McAnlis GT, McEneny J, Pearce J, Young IS. 1998. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr. 52:202–206.
  • Ohmori R, Iwamoto T, Tago M, Takeo T, Unno T, Itakura H, Kondo K. 2005. Antioxidant activity of various teas against free radicals and LDL oxidation. Lipids. 40:849–853.
  • O'Sullivan J, Mathison GE. 1970. Interference by monosaccharides with the estimation of tyrosine and proteins using the Folin-Ciocalteu phenol reagent. Anal Biochem. 35:540–542.
  • Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, . 1998. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 18:833–841.
  • Ratty AK, Sunamoto J, Das NP. 1988. Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochem Pharmacol. 37:989–995.
  • Ross R. 1995. Cell biology of atherosclerosis. Annu Rev Physiol. 57:791–804.
  • Sandstrom J, Nilsson P, Karlsson K, Marklund SL. 1994. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 26919166.
  • Stralin P, Karlsson K, Johansson BO, Marklund SL. 1995. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 15:2032–2036.
  • Takatsu H, Tasaki H, Kim HN, Ueda S, Tsutsui M, Yamashita K, . 2001. Overexpression of EC-SOD suppresses endothelial-cell-mediated LDL oxidation. Biochem Biophys Res Commun. 285:84–91.
  • Tasaki H, Yamashita K, Tsutsui M, Kamezaki F, Kubara T, Tanaka S, . 2006. Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis. Atherosclerosis. 187:131–138.
  • van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB. 1997. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 66:1125–1132.
  • Yoshida H, Ishikawa T, Ayaori M, Shige H, Hosoai H, Nishio E, . 1995. Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study. Clin Ther. 17:379–389.
  • Yoshida H, Ishikawa T, Hosoai H, Suzukawa M, Ayaori M, Hisada T, . 1999. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein. Biochem Pharmacol. 58:1695–1703.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.